Aprovel 150
Aprovel 150 is a medicine authorised by Swissmedic under authorisation number 54250. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 August 1997 and the authorisation is valid without a time limit. ATC code C09CA04 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 54250 |
|---|---|
| Name | Aprovel 150 |
| Full name | Aprovel 150, comprimés pelliculés |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09CA04 |
| First authorisation | 15 August 1997 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Aprovel 150, comprimés pelliculés | B | 15 August 1997 |
| 3 | Aprovel 300, comprimés pelliculés | B | 21 December 1999 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 118 | 28 | Tablette(n) | C09CA04 | 02.07.1. | B |
| 126 | 98 | Tablette(n) | C09CA04 | 02.07.1. | B |
| 134 | 28 | Tablette(n) | C09CA04 | 02.07.1. | B |
| 142 | 98 | Tablette(n) | C09CA04 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Aprovel 150 authorised in Switzerland?
Yes. Aprovel 150 is authorised by Swissmedic under authorisation number 54250, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Aprovel 150 have?
Aprovel 150 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Aprovel 150?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.